Somatic Reversion of Germline
BRCA2
Mutation Confers Resistance to Poly(ADP-ribose) Polymerase Inhibitor Therapy
JCO Precis Oncol
.
2018 Nov:2:1-6.
doi: 10.1200/PO.17.00044.
Authors
Kalyan Banda
1
,
Elizabeth M Swisher
1
,
David Wu
1
,
Colin C Pritchard
1
,
V K Gadi
1
Affiliation
1
All authors, University of Washington; Kalyan Banda and V.K. Gadi, Fred Hutchinson Cancer Research Center; and Elizabeth M. Swisher and V.K. Gadi, Seattle Cancer Care Alliance, Seattle, WA.
PMID:
35135104
DOI:
10.1200/PO.17.00044
No abstract available